Logo image of NVRO

NEVRO CORP (NVRO) Stock Fundamental Analysis

NYSE:NVRO - New York Stock Exchange, Inc. - US64157F1030 - Common Stock - Currency: USD

5.84  0 (0%)

After market: 5.8401 0 (0%)

Fundamental Rating

2

Overall NVRO gets a fundamental rating of 2 out of 10. We evaluated NVRO against 188 industry peers in the Health Care Equipment & Supplies industry. NVRO has a bad profitability rating. Also its financial health evaluation is rather negative. NVRO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

NVRO had negative earnings in the past year.
NVRO had a negative operating cash flow in the past year.
In the past 5 years NVRO reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: NVRO reported negative operating cash flow in multiple years.
NVRO Yearly Net Income VS EBIT VS OCF VS FCFNVRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

NVRO has a Return On Assets (-20.48%) which is comparable to the rest of the industry.
NVRO has a Return On Equity (-49.11%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -20.48%
ROE -49.11%
ROIC N/A
ROA(3y)-11.5%
ROA(5y)-13.58%
ROE(3y)-26.55%
ROE(5y)-28.86%
ROIC(3y)N/A
ROIC(5y)N/A
NVRO Yearly ROA, ROE, ROICNVRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

NVRO has a Gross Margin of 65.98%. This is in the better half of the industry: NVRO outperforms 68.06% of its industry peers.
In the last couple of years the Gross Margin of NVRO has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for NVRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.17%
GM growth 5Y-0.71%
NVRO Yearly Profit, Operating, Gross MarginsNVRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

NVRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NVRO has been increased compared to 1 year ago.
NVRO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NVRO is higher compared to a year ago.
NVRO Yearly Shares OutstandingNVRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NVRO Yearly Total Debt VS Total AssetsNVRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

NVRO has an Altman-Z score of -0.62. This is a bad value and indicates that NVRO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.62, NVRO perfoms like the industry average, outperforming 42.93% of the companies in the same industry.
A Debt/Equity ratio of 0.98 indicates that NVRO is somewhat dependend on debt financing.
NVRO has a Debt to Equity ratio of 0.98. This is in the lower half of the industry: NVRO underperforms 73.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z -0.62
ROIC/WACCN/A
WACC8.29%
NVRO Yearly LT Debt VS Equity VS FCFNVRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

NVRO has a Current Ratio of 4.62. This indicates that NVRO is financially healthy and has no problem in meeting its short term obligations.
NVRO's Current ratio of 4.62 is fine compared to the rest of the industry. NVRO outperforms 73.82% of its industry peers.
NVRO has a Quick Ratio of 3.62. This indicates that NVRO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NVRO (3.62) is better than 70.68% of its industry peers.
Industry RankSector Rank
Current Ratio 4.62
Quick Ratio 3.62
NVRO Yearly Current Assets VS Current LiabilitesNVRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

NVRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.29%, which is quite impressive.
NVRO shows a decrease in Revenue. In the last year, the revenue decreased by -3.92%.
The Revenue has been growing slightly by 0.92% on average over the past years.
EPS 1Y (TTM)25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y1.83%
Revenue growth 5Y0.92%
Sales Q2Q%-9.15%

3.2 Future

Based on estimates for the next years, NVRO will show a small growth in Earnings Per Share. The EPS will grow by 7.68% on average per year.
Based on estimates for the next years, NVRO will show a small growth in Revenue. The Revenue will grow by 4.43% on average per year.
EPS Next Y-29.92%
EPS Next 2Y-6.37%
EPS Next 3Y-1.23%
EPS Next 5Y7.68%
Revenue Next Year0.32%
Revenue Next 2Y2.33%
Revenue Next 3Y3.23%
Revenue Next 5Y4.43%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVRO Yearly Revenue VS EstimatesNVRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
NVRO Yearly EPS VS EstimatesNVRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NVRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NVRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVRO Price Earnings VS Forward Price EarningsNVRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVRO Per share dataNVRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.37%
EPS Next 3Y-1.23%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NVRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEVRO CORP

NYSE:NVRO (4/2/2025, 8:04:00 PM)

After market: 5.8401 0 (0%)

5.84

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners99.47%
Inst Owner Change-6.62%
Ins Owners2.02%
Ins Owner Change-65.44%
Market Cap221.22M
Analysts53.68
Price Target8.87 (51.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.9%
Min EPS beat(2)49.33%
Max EPS beat(2)50.46%
EPS beat(4)4
Avg EPS beat(4)42.48%
Min EPS beat(4)24.11%
Max EPS beat(4)50.46%
EPS beat(8)8
Avg EPS beat(8)30.85%
EPS beat(12)11
Avg EPS beat(12)217.02%
EPS beat(16)15
Avg EPS beat(16)164.13%
Revenue beat(2)2
Avg Revenue beat(2)1.5%
Min Revenue beat(2)0.92%
Max Revenue beat(2)2.09%
Revenue beat(4)3
Avg Revenue beat(4)0.05%
Min Revenue beat(4)-4.87%
Max Revenue beat(4)2.09%
Revenue beat(8)5
Avg Revenue beat(8)0.76%
Revenue beat(12)5
Avg Revenue beat(12)0.11%
Revenue beat(16)7
Avg Revenue beat(16)0.05%
PT rev (1m)0%
PT rev (3m)10.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.89%
EPS NY rev (1m)0.24%
EPS NY rev (3m)1.14%
Revenue NQ rev (1m)-1.34%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)-1.92
EYN/A
EPS(NY)-2.49
Fwd EYN/A
FCF(TTM)-0.77
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS10.78
BVpS6.1
TBVpS5.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.48%
ROE -49.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.98%
FCFM N/A
ROA(3y)-11.5%
ROA(5y)-13.58%
ROE(3y)-26.55%
ROE(5y)-28.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.17%
GM growth 5Y-0.71%
F-Score2
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.79%
Cap/Sales 2.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.62
Quick Ratio 3.62
Altman-Z -0.62
F-Score2
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)111.23%
Cap/Depr(5y)142.49%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y-29.92%
EPS Next 2Y-6.37%
EPS Next 3Y-1.23%
EPS Next 5Y7.68%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y1.83%
Revenue growth 5Y0.92%
Sales Q2Q%-9.15%
Revenue Next Year0.32%
Revenue Next 2Y2.33%
Revenue Next 3Y3.23%
Revenue Next 5Y4.43%
EBIT growth 1Y11.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.02%
EBIT Next 3Y28.25%
EBIT Next 5Y19.53%
FCF growth 1Y56.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.96%
OCF growth 3YN/A
OCF growth 5YN/A